1. bookVolume 30 (2022): Edizione 4 (October 2022)
Dettagli della rivista
License
Formato
Rivista
eISSN
2284-5623
Prima pubblicazione
08 Aug 2013
Frequenza di pubblicazione
4 volte all'anno
Lingue
Inglese
Open Access

Diagnostic value of combination of exfoliative cytology with CA125, CEA, NSE, CYFRA21-1 and CA15-3 for lung cancer

Pubblicato online: 20 Oct 2022
Volume & Edizione: Volume 30 (2022) - Edizione 4 (October 2022)
Pagine: 389 - 398
Ricevuto: 19 May 2022
Accettato: 18 Sep 2022
Dettagli della rivista
License
Formato
Rivista
eISSN
2284-5623
Prima pubblicazione
08 Aug 2013
Frequenza di pubblicazione
4 volte all'anno
Lingue
Inglese

1. Tokito T, Azuma K, Yamada K, Naito Y, Matsuo N, Ishii H, et al. Prognostic Value of Serum Tumor Markers in Patients With Stage III NSCLC Treated With Chemoradiotherapy. In Vivo. 2019;33(3):889-95. DOI: 10.21873/invivo.1155510.21873/invivo.11555655988531028213 Search in Google Scholar

2. Chen Z, Wang Y, Fang M. Analysis of tumor markers in pleural effusion and serum to verify the correlations between serum tumor markers and tumor size, TNM stage of lung adenocarcinoma. Cancer Med. 2020;9(4):1392-99. DOI: 10.1002/cam4.280910.1002/cam4.2809701307031881123 Search in Google Scholar

3. Tetikkurt C, Yılmaz N, Tetikkurt S, Gundogdu Ş, Disci R. The value of exfoliative cell cytology in the diagnosis of exudative pleural effusions. Monaldi Arch Chest Dis. 2018;88(3):944. DOI: 10.4081/monaldi.2018.94410.4081/monaldi.2018.94430203633 Search in Google Scholar

4. Nithin KU, Sridhar MG, Srilatha K, Habebullah S. CA 125 is a better marker to differentiate endometrial cancer and abnormal uterine bleeding. Afr Health Sci. 2018;18(4):972-8. DOI: 10.4314/ahs.v18i4.1710.4314/ahs.v18i4.17635488730766562 Search in Google Scholar

5. Gomes TA, Campos EA, Yoshida A, Sarian LO, Andrade LALA, Derchain SF. Preoperative Differentiation of Benign and Malignant Non-epithelial Ovarian Tumors: Clinical Features and Tumor Markers. Rev Bras Ginecol Obstet. 2020;42(9):555-61. DOI: 10.1055/s-0040-171299310.1055/s-0040-171299332992358 Search in Google Scholar

6. Georgantzi K, Sköldenberg EG, Stridsberg M, Kogner P, Jakobson Å, Janson ET, et al. Chromogranin A and neuron-specific enolase in neuroblastoma: Correlation to stage and prognostic factors. Pediatr Hematol Oncol. 2018;35(2):156-65. DOI: 10.1080/08880018.2018.146408710.1080/08880018.2018.146408729737901 Search in Google Scholar

7. Qu T, Zhang J, Xu N, Liu B, Li M, Liu A, et al. Diagnostic value analysis of combined detection of Trx, CYFRA21-1 and SCCA in lung cancer. Oncol Lett. 2019;17(5):4293-8. DOI: 10.3892/ol.2019.1007310.3892/ol.2019.10073644433130944623 Search in Google Scholar

8. Yu RZ, Huang MT. [The Diagnostic Value of Tumor Markers Combined with Fiberoptic Bronchoscopic Brushing in Lung Carcinoma]. Labeled Immunoassays and Clinical Medicine. 2014;21:360-3. Search in Google Scholar

9. Grunnet M, Sorensen JB. Carcinoembryonic antigen (CEA) as tumor marker in lung cancer. Lung Cancer. 2012;76(2):138-43. DOI: 10.1016/j.lung-can.2011.11.012 Search in Google Scholar

10. Villalobos P, Wistuba II. Lung Cancer Biomarkers. Hematol Oncol Clin North Am. 2017;31(1):13-29. DOI: 10.1016/j.hoc.2016.08.00610.1016/j.hoc.2016.08.006513780427912828 Search in Google Scholar

11. Duffy MJ, Sturgeon C, Lamerz R, Haglund C, Holubec VL, Klapdor R, et al. Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report. Ann Oncol. 2010;21(3):441-7. DOI: 10.1093/annonc/mdp33210.1093/annonc/mdp33219690057 Search in Google Scholar

12. O’Leary PC, Feddema PH, Michelangeli VP, Leedman PJ, Chew GT, Knuiman M, et al. Investigations of thyroid hormones and antibodies based on a community health survey: the Busselton thyroid study. Clin Endocrinol (Oxf). 2006;64(1):97-104. DOI: 10.1111/j.1365-2265.2005.02424.x10.1111/j.1365-2265.2005.02424.x16402936 Search in Google Scholar

13. Ferreiro L, Toubes ME, Valdés L. [Contribution of pleural fluid analysis to the diagnosis of pleural effusion]. Med Clin (Barc). 2015;145(4):171-7. DOI: 10.1016/j. medcli.2014.08.005 Search in Google Scholar

14. Duffy MJ, O’Byrne K. Tissue and Blood Biomarkers in Lung Cancer: A Review. Adv Clin Chem. 2018;86:1-21. DOI: 10.1016/bs.acc.2018.05.00110.1016/bs.acc.2018.05.00130144837 Search in Google Scholar

15. Allama AM, Abou-Elela DH, Ibrahim IM. Pleural and serum markers for diagnosis of malignant pleural effusion. Asian Cardiovasc Thorac Ann. 2020;28(9):560-5. DOI: 10.1177/021849232094831110.1177/021849232094831132741198 Search in Google Scholar

16. Dal Bello MG, Filiberti RA, Alama A, Orengo AM, Mussap M, Coco S, et al. The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients. J Transl Med. 2019;17(1):74. DOI: 10.1186/s12967-019-1828-010.1186/s12967-019-1828-0640878430849967 Search in Google Scholar

17. Hao C, Zhang G, Zhang L. Serum CEA levels in 49 different types of cancer and noncancer diseases. Prog Mol Biol Transl Sci. 2019;162:213-27. DOI: 10.1016/bs.pmbts.2018.12.01110.1016/bs.pmbts.2018.12.01130905451 Search in Google Scholar

18. Osanyin GE, Okunade KS, Ayotunde Oluwole A. Association between serum CA125 levels in preeclampsia and its severity among women in Lagos, South-West Nigeria. Hypertens Pregnancy. 2018;37(2):93-7. DOI: 10.1080/10641955.2018.146066710.1080/10641955.2018.146066729718786 Search in Google Scholar

19. Chen C, Chen Q, Zhao Q, Liu M, Guo J. Value of Combined Detection of Serum CEA, CA72-4, CA19-9, CA15-3 and CA12-5 in the Diagnosis of Gastric Cancer. Ann Clin Lab Sci. 2017;47(3):260-3. Search in Google Scholar

20. Wang B, He YJ, Tian YX, Yang RN, Zhu YR, Qiu H. Clinical utility of haptoglobin in combination with CEA, NSE and CYFRA21-1 for diagnosis of lung cancer. Asian Pac J Cancer Prev. 2014;15(22):9611-4. DOI: 10.7314/APJCP.2014.15.22.961110.7314/APJCP.2014.15.22.961125520076 Search in Google Scholar

21. Ren X, Zhang Y, Lyu Y, Jin B, Guo H, Wu J, et al. Lac-tate dehydrogenase and serum tumor markers for predicting metastatic status in geriatric patients with lung adenocarcinoma. Cancer Biomark. 2019;26(2):139-50. DOI: 10.3233/CBM-19020110.3233/CBM-19020131356196 Search in Google Scholar

Articoli consigliati da Trend MD

Pianifica la tua conferenza remota con Sciendo